This prospective, randomized controlled trial aims to assess the effects of Heartfulness meditation on various psychological and molecular parameters associated with mental health. With growing global awareness of the burden of mental health disorders, this study investigates how a structured meditation practice like Heartfulness can influence both subjective mental well-being and objective biological markers. The primary aim of the study is to evaluate the potential of Heartfulness meditation on psychological symptoms such as depression, anxiety, and stress, as well as on gene expression patterns linked to stress and anxiety regulation. Secondly, the study will evaluate circadian rhythm patterns and biological clock alignment through standardized questionnaires and gene expression. Disruptions in circadian rhythm are known to contribute to mental health disorders, and meditation has been suggested to help restore rhythm synchrony.

Recent research has shown that lifestyle factors, including meditation, can lead to epigenetic changes such as heritable changes in gene activity without alterations in the DNA sequence itself. Mindfulness-based interventions have been linked to reduced expression of pro-inflammatory genes and enhanced regulation of stress-responsive genes. However, there is limited data on Heartfulness meditation. By bridging psychometric assessments with molecular biology, this study aims to provide holistic insights into the potential of Heartfulness meditation. The findings could significantly contribute to the field of mind-body medicine by identifying biological mechanisms through which meditation improves mental health and restores circadian balance. Ultimately, the research could support the integration of meditative practices into mainstream mental health care, offering non-pharmacological options for stress and anxiety management.